This webinar will examine the renewed issue of microbial contamination of raw materials and why the FDA, EMA and Health Canada have recently focused on this.  The revised ICH Q7 “Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients“ will also be discussed.